\
&
Contact us
Background stories of how others approached and experienced their European Horizon funding trajectory.
Published on | 11 months ago
Programmes HealthThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
Read the full article for details
Circusol is an Innovation Action project funded under a cross-cutting work programme part of Horizon 2020. Circusol aims at unleashing the full potential of circular business models, in particular Product-Service Systems, in simultaneously delivering real environmental, economic and user benefits. By that, Circusol aims to establish solar power as a spearhead sector in demonstrating a path driven by service-based businesses towards a circular economy in Europe.
A strong Flemish partnership in new Horizon 2020 project on circular economy business demonstrators, including VITO (Coordinator), IMEC, Ecopower cvba, Futech bvba, PV Cycle aisbl and Daidalos Peutz bvba.